Dr. Brenda Raud is a postdoctoral researcher at the Netherlands Cancer Institute. Her research focuses on T-cell-based immunotherapies and immuno-oncology. Dr. Jason Goldsmith recently completed his postdoctoral fellowship at the University of Pennsylvania, and is now the Director of Donor Medical Sciences at Seres Therapeutics, a biotechnology company working to revolutionize treatment of a wide range of diseases by modulating the function of the human microbiome.

In addition to their work as researchers, Brenda and Jason are also hosts of the new Immunology Podcast, a sister podcast to the Stem Cell Podcast, launching on March 30th.

Listen to the episode here.